Biomarkers and surrogate endpoints. Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
Google Scholar
Lee, J. W. et al. Fit-for-Purpose method development…
Biomarkers and surrogate endpoints. Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
Google Scholar
Lee, J. W. et al. Fit-for-Purpose method development…